chr15-78474287-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000560440.5(IREB2):c.*897C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.506 in 151,972 control chromosomes in the GnomAD database, including 20,815 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.51 ( 20815 hom., cov: 32)
Exomes 𝑓: 0.25 ( 0 hom. )
Consequence
IREB2
ENST00000560440.5 3_prime_UTR
ENST00000560440.5 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -3.25
Publications
10 publications found
Genes affected
IREB2 (HGNC:6115): (iron responsive element binding protein 2) The protein encoded by this gene is an RNA-binding protein that acts to regulate iron levels in the cells by regulating the translation and stability of mRNAs that affect iron homeostasis under conditions when iron is depleted. When iron levels are low, this protein binds to iron-responsive elements (IRES), stem-loop structures located either in the 5' or 3' UTRs. Binding to the 5' UTR represses translation, while binding to the 3' UTR inhibits mRNA degradation. When iron is found in the cell, this protein is degraded in a F-box and leucine rich repeat protein 5-dependent manner. Variants in this gene have been associated with lung cancer and chronic obstructive pulmonary disease (COPD). Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2017]
IREB2 Gene-Disease associations (from GenCC):
- neurodegeneration, early-onset, with choreoathetoid movements and microcytic anemiaInheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.613 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| IREB2 | NM_004136.4 | c.1023+906C>T | intron_variant | Intron 8 of 21 | ENST00000258886.13 | NP_004127.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| IREB2 | ENST00000560440.5 | c.*897C>T | 3_prime_UTR_variant | Exon 8 of 8 | 1 | ENSP00000452938.1 | ||||
| IREB2 | ENST00000258886.13 | c.1023+906C>T | intron_variant | Intron 8 of 21 | 1 | NM_004136.4 | ENSP00000258886.8 | |||
| IREB2 | ENST00000558570.5 | n.*290+906C>T | intron_variant | Intron 7 of 20 | 1 | ENSP00000454063.1 |
Frequencies
GnomAD3 genomes AF: 0.506 AC: 76801AN: 151850Hom.: 20803 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
76801
AN:
151850
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.250 AC: 1AN: 4Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 2 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 exome
AF:
AC:
1
AN:
4
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
2
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AC:
0
AN:
0
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
AC:
1
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AC:
0
AN:
0
Other (OTH)
AF:
AC:
0
AN:
2
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.275
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.506 AC: 76835AN: 151968Hom.: 20815 Cov.: 32 AF XY: 0.505 AC XY: 37533AN XY: 74278 show subpopulations
GnomAD4 genome
AF:
AC:
76835
AN:
151968
Hom.:
Cov.:
32
AF XY:
AC XY:
37533
AN XY:
74278
show subpopulations
African (AFR)
AF:
AC:
12582
AN:
41410
American (AMR)
AF:
AC:
7595
AN:
15268
Ashkenazi Jewish (ASJ)
AF:
AC:
1910
AN:
3462
East Asian (EAS)
AF:
AC:
2401
AN:
5168
South Asian (SAS)
AF:
AC:
2307
AN:
4814
European-Finnish (FIN)
AF:
AC:
6183
AN:
10546
Middle Eastern (MID)
AF:
AC:
158
AN:
294
European-Non Finnish (NFE)
AF:
AC:
41993
AN:
67980
Other (OTH)
AF:
AC:
1081
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1814
3628
5442
7256
9070
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
690
1380
2070
2760
3450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1504
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.